{
    "medicine_id": "47ab2c4245e4bd4ac1ad2bc92beb7afaef3e9f13",
    "platform_id": "14532",
    "metadata": {
        "name": "Montelukast 4 mg chewable tablets",
        "composition": "Each chewable tablet contains 4 mg montelukast as montelukast sodium",
        "clinical_particulars": {
            "therapeutic_indications": "Montelukast is indicated in the treatment of asthma as add on therapy in those 2 to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom as needed short acting \u03b2 agonists provide inadequate clinical control of asthma Montelukast may also be an alternative treatment option to low dose inhaled corticosteroids for 2 to 5 year old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use and who have demonstrated that they are not capable of using inhaled corticosteroids see section 4 2 Montelukast is also indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise induced bronchoconstriction",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Mannitol (E421);Cellulose, microcrystalline;Croscarmellose sodium;Hydroxypropylcellulose;Aspartame (E951);Iron oxide, red (E172);Flavour cherry black (also contains glyceryl triacetate (E1518));Magnesium stearate",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2019-11-15"
    }
}